Teach-Back Educational Method On Diabetes Knowledge Level
The Impact Of Teach-Back Educational Method On Diabetes Knowledge Level And Clinical Parameters In Type 2 Diabetes Patients Undergoing Insulin Therapy
1 other identifier
interventional
130
1 country
1
Brief Summary
It was aimed to research the effect of teach-back educational method on diabetes knowledge level and clinical parameters in type 2 diabetes patients undergoing insulin therapy. This is a randomized-controlled trial. Teach-back method will used for intervention group, routin diabetes education will used for control group. The primary outcome is diabetes knowledge levels (DKL), and secondary outcome is clinical patameters (fasting blood glucose, HbA1c, blood pressure). DKL and clinical parameters will measured and compared between two groups before and three months after the interventions.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Apr 2019
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2019
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2019
CompletedFirst Submitted
Initial submission to the registry
August 7, 2020
CompletedFirst Posted
Study publicly available on registry
August 12, 2020
CompletedAugust 12, 2020
August 1, 2020
3 months
August 7, 2020
August 10, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Diabetes knowledge level (DKL)
The DKL will be measured through a self-structured questionnaire containing 11 items. The questionnaire contains three answers: "yes," "no," or "I do not know." The right answer will be accepted as two points, the wrong answer as zero points, and the "I do not know" answer will be accepted as one point. The total scores ranges from 0-22. Higher scores of the questionnaire indicates that the higher DKL.
3 months
Secondary Outcomes (3)
Fasting blood glucose
3 months
HbA1c
3 months
Blood pressure
3 months
Study Arms (2)
Control Group
NO INTERVENTIONRoutine diabetes education will given to the patients included in the Control Group by a diabetes education nurse. The diabetes education nurse has been working for 10 years in the same center.
Intervention Group
EXPERIMENTALIntervention Group will take their diabetes education by teach-back educational strategy.
Interventions
In the teach-back method, after teaching new information to the patient, the patients were asked to explain that new information in their own words. Then the patients' knowledge and the adequateness of their explanations were determined. The patient should repeat the instructions in their own words. In this way, the healthcare professional can evaluate how the patient understands the information. If the patient repeated the information correctly, the teach-back phase for that information was completed, and progression for new information was resumed. However, if there was a deficiency or error in the information, it was corrected and repeated by the healthcare professional.
Eligibility Criteria
You may qualify if:
- To have Type 2 Diabetes
- To be over 18 years old
- Not have any barriers in understanding and speaking Turkish
- Who started insulin treatment for the first time
You may not qualify if:
- Patients with a diagnosis of dementia
- To have vision or hearing loss
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ataturk University Hospital
Erzurum, 25040, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Yasemin Cayir, 1
Ataturk University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
August 7, 2020
First Posted
August 12, 2020
Study Start
April 1, 2019
Primary Completion
June 30, 2019
Study Completion
July 31, 2019
Last Updated
August 12, 2020
Record last verified: 2020-08
Data Sharing
- IPD Sharing
- Will not share
The clinical outcomes will be shared.